A recent study with neutrophils from chronic granulomatous disease (CGD) patients, who suffer a primary immunodeficiency resulting from inactivating mutations in NADPH oxidase, revealed novel insight into neutrophil calcium homeostasis and LTB4 production (Song et al., 2020). Here, FMO5 is linked to chronic granulomatous disease.